The cost implications of the use of pegylated liposomal doxorubicin when choosing an anthracycline for the treatment of platinum-resistant ovarian cancer: A low-value intervention?

Cohn DE, Shimp WS
Gynecol Oncol Rep 13 47-8 08/01/2015

Abstract

Full Text